Stonepine Capital Management LLC bought a new stake in Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) in the second quarter, Holdings Channel reports. The institutional investor bought 77,900 shares of the biotechnology company’s stock, valued at approximately $132,000. Invivo Therapeutics comprises about 0.1% of Stonepine Capital Management LLC’s holdings, making the stock its 25th biggest holding.
Separately, Renaissance Technologies LLC bought a new position in shares of Invivo Therapeutics in the second quarter valued at approximately $211,000. Institutional investors own 9.32% of the company’s stock.
Shares of NASDAQ:NVIV remained flat at $$1.94 during trading on Thursday. 16,120 shares of the stock were exchanged, compared to its average volume of 90,685. Invivo Therapeutics Holdings Corp has a 52 week low of $1.63 and a 52 week high of $56.25. The company has a market capitalization of $15.14 million, a PE ratio of -0.10 and a beta of 2.21.
Invivo Therapeutics (NASDAQ:NVIV) last posted its earnings results on Tuesday, August 7th. The biotechnology company reported ($7.48) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.41) by ($7.07). research analysts forecast that Invivo Therapeutics Holdings Corp will post -11.58 EPS for the current year.
Separately, ValuEngine upgraded shares of Invivo Therapeutics from a “strong sell” rating to a “sell” rating in a research note on Friday, June 1st.
About Invivo Therapeutics
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for implantation at the site of injury within a spinal cord.
Recommended Story: Hedge Funds
Want to see what other hedge funds are holding NVIV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invivo Therapeutics Holdings Corp (NASDAQ:NVIV).
Receive News & Ratings for Invivo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invivo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.